Original article

Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss setting

KM Erny-Albrecht, E Erdmann

DOI: https://doi.org/10.4414/smw.2009.12381
Publication Date: 21.03.2009
Swiss Med Wkly. 2009;139(11-12):173

This text is only available as PDF .